MONAS
FINANCIAL
Home
About
Research
Data
Pricing
Team
News
Analysis
Press
Contact
Legal
← News
Amgen Raises FY2026 GAAP EPS Guidance from $15.80-$17.08 to $18.34-$19.28 vs $15.90 Est
News
AMGN
Nov 3
AI-curated analysis for informational purposes only — not investment advice.
Amgen Raises FY2026 GAAP EPS Guidance from $15.80-$17.08 to $18.34-$19.28 vs $15.90 Est
Read the full story at benzinga.com →